NEW YORK (GenomeWeb News) - Japanese pharmaceutical company Eisai has licensed Rosetta Biosoftware's Elucidator protein expression and biomarker discovery system, Rosetta said yesterday.
Seattle-based Rosetta said Eisai plans to use the Elucidator system to support LC/MS methods for biomarker research in neurology at the Laboratory of Seeds Finding Technology
Elucidator enables data management and analysis workflow for comparative proteomics, Rosetta said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.

Sponsored by
Philips Genomics

This webinar will highlight a comprehensive end-to-end solution for precision care in oncology, comprising sample acquisition through to sequencing and analysis, treatment recommendations, and follow-through.